Prostate Cancer - Results from #40

Adverse Events and Androgen Receptor Signaling Inhibitors in the Treatment of Prostate Cancer: A Systematic Review and Multivariate Network Meta-analysis. January 24, 2023

Androgen receptor activity in T cells limits checkpoint blockade efficacy. January 24, 2023

Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs? January 23, 2023

Relugolix: A Review in Advanced Prostate Cancer. January 23, 2023

Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities. January 23, 2023

Towards Single Time Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy. January 23, 2023

Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts. January 23, 2023

Response to bipolar androgen therapy and PD-1 inhibition in a patient with metastatic castration-resistant prostate cancer and a germline CHEK2 mutation. January 20, 2023

Racial Differences in Germline Genetic Testing for Prostate Cancer: A Systematic Review. January 20, 2023

Implementation of a Telehealth Genetic Testing Station to Deliver Germline Testing for Men With Prostate Cancer. January 20, 2023

Clinical performance of MRI & biomarkers for prostate cancer diagnosis in men at high genetic risk. January 20, 2023

Role of Race and Insurance Status in Prostate Cancer Diagnosis-to-Treatment Interval. January 20, 2023

Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy. January 19, 2023

Interobserver Reproducibility of Cribriform Cancer in Prostate Needle Biopsies and Validation of International Society of Urological Pathology Criteria. January 19, 2023

Automated deep-learning system in the assessment of MRI-visible prostate cancer: comparison of advanced zoomed diffusion-weighted imaging and conventional technique. January 19, 2023

Improved diffusion-weighted imaging of the prostate: Comparison of readout-segmented and zoomed single-shot imaging. January 19, 2023

CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. January 19, 2023

The next generation of evidence-based medicine. January 19, 2023

Analysis of the financial impact and efficiency of the One Stop Prostate Clinic: A same day prostate cancer diagnostic clinic in the Australian public health system. January 18, 2023

Same day discharge for robot-assisted radical prostatectomy: a prospective cohort study documenting an Australian approach. January 18, 2023

Page 3 of 1276

email news signup